Biogen, Inc. (BIIB)
184.02
-4.03
(-2.14%)
USD |
NASDAQ |
Mar 03, 16:00
183.92
-0.10
(-0.05%)
After-Hours: 20:00
Biogen Price : 184.02 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1007.73 |
| AbbVie, Inc. | 233.86 |
| Stoke Therapeutics, Inc. | 33.78 |
| Merck & Co., Inc. | 119.83 |
| Alnylam Pharmaceuticals, Inc. | 318.65 |
Price Related Metrics
| PE Ratio | 20.90 |
| PS Ratio | 2.833 |
| Price to Book Value | 1.479 |
| Price to Free Cash Flow | 13.72 |
| Earnings Yield | 4.79% |
| Market Cap | 27.01B |
| Operating PE Ratio | 11.16 |
| Normalized PE Ratio | 15.78 |